ETF Series Solutions - Loncar Cancer Immunotherapy ETF
LEI: 549300MLI82YH9HOGS11
ETF Series Solutions - Loncar Cancer Immunotherapy ETF
en
C/O The Corporation Trust Company
Corporation Trust Center
1209 Orange Street
Wilmington, Delaware (US-DE), 19801
UNITED STATES
c/o Exchange Traded Concepts, LLC
3555 NW 58th ST
Suite 600
Oklahoma, Oklahoma (US-OK), 73112
UNITED STATES
UNITED STATES (US)
Securities and Exchange Commission (RA000665)
S000050740
Other (8888)
Fund
FUND
ACTIVE
2018-08-14 00:00:00
NON_CONSOLIDATING
2018-08-14 00:00:00
RELATIONSHIP_PERIOD
ACTIVE
2023-05-05 13:43:14
2023-05-05 13:43:14
LAPSED
FULLY_CORROBORATED
SUPPORTING_DOCUMENTS
2018-08-14 00:00:00
RELATIONSHIP_PERIOD
ACTIVE
2023-05-05 13:43:14
2023-05-05 13:43:14
LAPSED
FULLY_CORROBORATED
SUPPORTING_DOCUMENTS
2015-08-07 01:36:00
2023-05-05 13:43:14
2023-03-05 16:24:55
TRANSFERRED
FULLY_CORROBORATED
Securities and Exchange Commission (RA000665)
S000050740